Related references
Note: Only part of the references are listed.Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk
Lars J. Grimm et al.
ACADEMIC RADIOLOGY (2019)
A Novel Animal Model of Induced Breast Precancerous Lesion in Tree Shrew
Maojian Chen et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
Yuting Sang et al.
MOLECULAR THERAPY (2019)
Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer
Qiang Zhou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Eugenol alleviated breast precancerous lesions through HER2/PI3K-AKT pathway-induced cell apoptosis and S-phase arrest
Min Ma et al.
ONCOTARGET (2017)
Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study
Margarita Posso et al.
CANCER MEDICINE (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice
Fang-Fang Gao et al.
BIOMEDICAL REPORTS (2016)
Anti-metastatic effect and mechanisms of Wenshen Zhuanggu Formula in human breast cancer cells
Xiang-hui Han et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
The Role of Traditional Chinese Herbal Medicines in Cancer Therapy - from TCM Theory to Mechanistic Insights
W. L. Wendy Hsiao et al.
PLANTA MEDICA (2010)
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
Clare G. Fedele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Share Paper
